These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

467 related articles for article (PubMed ID: 33098803)

  • 21. Neuroinflammation PET Imaging: Current Opinion and Future Directions.
    Jain P; Chaney AM; Carlson ML; Jackson IM; Rao A; James ML
    J Nucl Med; 2020 Aug; 61(8):1107-1112. PubMed ID: 32620705
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Molecular imaging of microglia/macrophages in the brain.
    Venneti S; Lopresti BJ; Wiley CA
    Glia; 2013 Jan; 61(1):10-23. PubMed ID: 22615180
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In vivo expression of cyclooxygenase-1 in activated microglia and macrophages during neuroinflammation visualized by PET with 11C-ketoprofen methyl ester.
    Shukuri M; Takashima-Hirano M; Tokuda K; Takashima T; Matsumura K; Inoue O; Doi H; Suzuki M; Watanabe Y; Onoe H
    J Nucl Med; 2011 Jul; 52(7):1094-101. PubMed ID: 21680698
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In Vivo Detection of Age- and Disease-Related Increases in Neuroinflammation by 18F-GE180 TSPO MicroPET Imaging in Wild-Type and Alzheimer's Transgenic Mice.
    Liu B; Le KX; Park MA; Wang S; Belanger AP; Dubey S; Frost JL; Holton P; Reiser V; Jones PA; Trigg W; Di Carli MF; Lemere CA
    J Neurosci; 2015 Nov; 35(47):15716-30. PubMed ID: 26609163
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Markers of central inflammation in major depressive disorder: A systematic review and meta-analysis of studies examining cerebrospinal fluid, positron emission tomography and post-mortem brain tissue.
    Enache D; Pariante CM; Mondelli V
    Brain Behav Immun; 2019 Oct; 81():24-40. PubMed ID: 31195092
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Impact of hydroxytyrosol on stroke: tracking therapy response on neuroinflammation and cerebrovascular parameters using PET-MR imaging and on functional outcomes.
    Barca C; Wiesmann M; Calahorra J; Wachsmuth L; Döring C; Foray C; Heiradi A; Hermann S; Peinado MÁ; Siles E; Faber C; Schäfers M; Kiliaan AJ; Jacobs AH; Zinnhardt B
    Theranostics; 2021; 11(9):4030-4049. PubMed ID: 33754046
    [TBL] [Abstract][Full Text] [Related]  

  • 27. PET Imaging of Adenosine Receptors in Diseases.
    Li J; Hong X; Li G; Conti PS; Zhang X; Chen K
    Curr Top Med Chem; 2019; 19(16):1445-1463. PubMed ID: 31284861
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [
    Kaneko KI; Irie S; Mawatari A; Igesaka A; Hu D; Nakaoka T; Hayashinaka E; Wada Y; Doi H; Watanabe Y; Cui Y
    Eur J Nucl Med Mol Imaging; 2022 Jun; 49(7):2265-2275. PubMed ID: 35157105
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Positron emission tomography applications in clinical neurology.
    Singhal T
    Semin Neurol; 2012 Sep; 32(4):421-31. PubMed ID: 23361486
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Neuroinflammation in neurodegenerative disorders: the roles of microglia and astrocytes.
    Kwon HS; Koh SH
    Transl Neurodegener; 2020 Nov; 9(1):42. PubMed ID: 33239064
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Imaging Neuroinflammation in Neurodegenerative Disorders.
    Masdeu JC; Pascual B; Fujita M
    J Nucl Med; 2022 Jun; 63(Suppl 1):45S-52S. PubMed ID: 35649654
    [TBL] [Abstract][Full Text] [Related]  

  • 32.
    Joya A; Ardaya M; Montilla A; Garbizu M; Plaza-García S; Gómez-Vallejo V; Padro D; Gutiérrez JJ; Rios X; Ramos-Cabrer P; Cossío U; Pulagam KR; Higuchi M; Domercq M; Cavaliere F; Matute C; Llop J; Martín A
    Theranostics; 2021; 11(1):410-425. PubMed ID: 33391483
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Neuroinflammation in acute hepatic encephalopathy rats: imaging and therapeutic effectiveness evaluation using
    Luo S; Kong X; Wu JR; Wang CY; Tian Y; Zheng G; Su YY; Lu GM; Zhang LJ; Yang GF
    Metab Brain Dis; 2018 Oct; 33(5):1733-1742. PubMed ID: 29968208
    [TBL] [Abstract][Full Text] [Related]  

  • 34. PET brain imaging in neurological disorders.
    Xie L; Zhao J; Li Y; Bai J
    Phys Life Rev; 2024 Jul; 49():100-111. PubMed ID: 38574584
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In vivo imaging of microglial activation by positron emission tomography with [(11)C]PBR28 in the 5XFAD model of Alzheimer's disease.
    Mirzaei N; Tang SP; Ashworth S; Coello C; Plisson C; Passchier J; Selvaraj V; Tyacke RJ; Nutt DJ; Sastre M
    Glia; 2016 Jun; 64(6):993-1006. PubMed ID: 26959396
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Neuroinflammation in Neurodegenerative Diseases: Current Multi-modal Imaging Studies and Future Opportunities for Hybrid PET/MRI.
    Aiello M; Cavaliere C; Fiorenza D; Duggento A; Passamonti L; Toschi N
    Neuroscience; 2019 Apr; 403():125-135. PubMed ID: 30071279
    [TBL] [Abstract][Full Text] [Related]  

  • 37. PET molecular imaging in stem cell therapy for neurological diseases.
    Wang J; Tian M; Zhang H
    Eur J Nucl Med Mol Imaging; 2011 Oct; 38(10):1926-38. PubMed ID: 21698414
    [TBL] [Abstract][Full Text] [Related]  

  • 38. PET Imaging of Neuroinflammation in Alzheimer's Disease.
    Zhou R; Ji B; Kong Y; Qin L; Ren W; Guan Y; Ni R
    Front Immunol; 2021; 12():739130. PubMed ID: 34603323
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Targeting neuroinflammation with brain penetrant P2X7 antagonists as novel therapeutics for neuropsychiatric disorders.
    Bhattacharya A; Ceusters M
    Neuropsychopharmacology; 2020 Jan; 45(1):234-235. PubMed ID: 31477815
    [No Abstract]   [Full Text] [Related]  

  • 40. Neuroinflammation: Molecular Mechanisms And Therapeutic Perspectives.
    Marino M; Mele E; Pastorino GMG; Meccariello R; Operto FF; Santoro A; Viggiano A
    Cent Nerv Syst Agents Med Chem; 2022; 22(3):160-174. PubMed ID: 36177627
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.